Drug Shortage Report for TEVA-TOPISONE

Last updated on 2018-01-03 History
Report ID 8055
Drug Identification Number 00809187
Brand name RATIO-TOPISONE
Common or Proper name TOPISONE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BETAMETHASONE
Strength(s) 0.05%
Dosage form(s) LOTION
Route of administration TOPICAL
Packaging size 30ML
ATC code D07AC
ATC description CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-04-21
Estimated end date 2017-12-19
Actual end date 2017-12-29
Shortage status Resolved
Updated date 2018-01-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-01-03 French Compare
v9 2018-01-03 English Compare
v8 2017-11-06 French Compare
v7 2017-11-06 English Compare
v6 2017-09-19 French Compare
v5 2017-09-19 English Compare
v4 2017-05-08 French Compare
v3 2017-05-08 English Compare
v2 2017-04-25 French Compare
v1 2017-04-25 English Compare

Showing 1 to 10 of 10